CD274 and head and neck squamous cell carcinoma: A very interesting discovery concerns the inhibitory action on the expression of PD-L1, one of the main immune escape mechanisms of HNSCC, and the target of new immunotherapy based on immune checkpoint inhibitors [62,63].